Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

A worse prognosis for incomplete revascularization in both angioplasty and surgery.

Original title: The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total Occlusions. The SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) Trial. Reference: Vasim Farooq et al. J Am Coll Cardiol 2013;61:282–94

In patients with complex coronary artery disease who underwent coronary artery bypass surgery, (CABG), or percutaneous transluminal coronary angioplasty, (PTCA), the long-term prognosis of complete versus incomplete revascularization is unclear. 

In fact, recent studies suggest that complete revascularization when receiving CABG does not significantly improve the long-term prognosis. The aim of this study was to report the long-term clinical impact, (4 years), of the complete or incomplete angiography revascularization in all patients, “all-comers”, of the SYNTAX study, (both randomized and those included in the record of CABG and PTCA). With a total of 2,636 patients, complete revascularization was achieved in 52.8% of those receiving PTCA, (n = 1095), and 66.9% of those receiving CABG, (n = 1541). 

Patients with incomplete revascularization had a greater anatomical complexity, (high SYNTAX score and total occlusions), more comorbidities, (higher EuroSCORE), and a lower incidence of injury to the left coronary trunk. In both branches incomplete revascularization, (compared to complete), was associated with a significant increase in mortality at 4 years, of revascularization, stent thrombosis and major cardiovascular and cerebrovascular events (MACCE). The biggest predictor of incomplete revascularization for PTCA branch were total occlusions and for the CABG branch left dominance. Complete revascularization in patients with total occlusions was associated with lower stent thrombosis at 4 years in the PTCA branch as well as minor occlusion of the bridges in the CABG branch.

Conclusion: 

In both branches, angioplasty and surgery, incomplete angiographic revascularization seems to be connected to anatomical complexity and clinical comorbidities. It has a long-term negative impact on all events including mortality.

Editorial Comment: 

The results of this post hoc study should be considered as hypothesis but generating, nevertheless, many interesting facts. For example, patients with incomplete revascularization presented high stent thrombosis despite receiving fewer stents and the total length was significantly less treated. This could be explained by a more challenging anatomy with a poor distal bed and severe calcification. In the CABG branch patients with complete revascularization without occlusions had higher occlusions of the bridges that those that had total occlusions. Perhaps the bridges connected to uninjured arteries actually present flow competition and tend to occlude over time. Finally, the concepts of “reasonable” or “acceptable” revascularization are emerging but it is unclear what percentage of ischemic myocardium we can “tolerate” and if angiography should be replaced by the fractional flow reserve, (FFR), to complete the divide of incomplete occlusions.

SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...